The role of caspase activity in the viral response of pegylated interferon alfa-2B plus ribavirin therapy

被引：0
|
作者：
Oze, Tsugiko
Hiramatsu, Naoki
Kanto, Tatsuya
Kurashige, Nao
Yakushijin, Takayuki
Uyama, Hirokazu
Igura, Takumi
Oshita, Masahide
Katayama, Kazuhiro
Yoshihara, Harumasa
Imai, Yasuharu
Kato, Michio
Takehara, Tetsuo
Kasahara, Akinori
Tamura, Shinji
Hayashi, Norio
机构：
[1] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka, Japan
[2] Osaka Police Hosp, Osaka, Japan
[3] Osaka Kouseinenkin Hosp, Osaka, Japan
[4] Osaka Rousai Hosp, Sakai, Osaka, Japan
[5] Ikeda City Hosp, Ikeda, Osaka, Japan
[6] Osaka Natl Hosp, Natl Hosp Org, Osaka, Japan
来源：
HEPATOLOGY | 2006年 / 44卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
333
引用
收藏
页码：313A / 314A
页数：2
相关论文
共 50 条
  • [1] Pegylated interferon alfa-2b plus ribavirin in the retreatment of interferon-ribavirin nonresponder patients
    Taliani, G
    Gemignani, G
    Ferrari, C
    Aceti, A
    Bartolozzi, D
    Blanc, PL
    Capanni, M
    Esperti, F
    Forte, P
    Guadagnino, V
    Mari, T
    Marino, N
    Milani, S
    Pasquazzi, C
    Rosina, F
    Tacconi, D
    Toti, M
    Zignego, AL
    Messerini, L
    Stroffolini, T
    GASTROENTEROLOGY, 2006, 130 (04) : 1098 - 1106
  • [2] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    PN Rao
    Abraham Koshy
    Jacob Philip
    Narayanan Premaletha
    Joy Varghese
    Krishnasamy Narayanasamy
    Samir Mohindra
    Nitin Vikas Pai
    Manoj Kumar Agarwal
    Ashokna Konar
    Hasmukh B Vora
    World Journal of Hepatology, 2014, (07) : 520 - 526
  • [3] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    Rao, P. N.
    Koshy, Abraham
    Philip, Jacob
    Premaletha, Narayanan
    Varghese, Joy
    Narayanasamy, Krishnasamy
    Mohindra, Samir
    Pai, Nitin Vikas
    Agarwal, Manoj Kumar
    Konar, Ashoknanda
    Vora, Hasmukh B.
    WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (07) : 520 - 526
  • [4] SHORT DURATION THERAPY OF PEGYLATED INTERFERON ALFA-2B PLUS RIBAVIRIN FOR HCV GENOTYPE 2 PATIENTS
    Katano, Yoshiaki
    Ishigami, Mosatashi
    Nakano, Isao
    Hayashi, Kazuhiko
    Honda, Takashi
    Goto, Hidemi
    HEPATOLOGY, 2008, 48 (04) : 1146A - 1147A
  • [5] Hashimoto encephalopathy with pegylated interferon alfa-2b and ribavirin
    Deutsch, M
    Koskinas, J
    Tzannos, K
    Vassilopoulos, D
    Mailis, A
    Tolis, G
    Hadziyannis, S
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (10) : 1745 - 1748
  • [6] Interstitial pneumonitis due to pegylated interferon alfa-2b and ribavirin
    Nemivant, RR
    Hammadeh, R
    Shah, N
    Villanueva, J
    CHEST, 2003, 124 (04) : 242S - 242S
  • [7] Pegylated interferon alfa-2b plus ribavirin in the re-treatment of interferon-ribavirin non responder patients
    Taliani, Gloria
    Gemignani, Giulia
    Ferrari, Carlo
    Aceti, Antonio
    Bartolozzi, Dario
    Blanc, Pier Luigi
    Capanni, Marco
    Esperti, Francesco
    Forte, Paolo
    Guadagnino, Vincenzo
    Mari, Terenzio
    Marino, Nicoletta
    Milani, Stefano
    Pasquazzi, Caterina
    Tacconi, Danilo
    Toti, Mario
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A124 - A125
  • [8] Treatment with pegylated interferon alfa-2b in combination with ribavirin improved health-related quality of life compared with interferon alfa-2b plus ribavirin in chronic hepatitis C.
    Gish, R
    Rzowej, N
    Brooks, L
    Brass, C
    Weng, W
    HEPATOLOGY, 2002, 36 (04) : 582A - 582A
  • [9] Indications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapy
    Oze, Tsugiko
    Hiramatsu, Naoki
    Yakushijin, Takayuki
    Mochizuki, Kiyoshi
    Oshita, Masahide
    Hagiwara, Hideki
    Mita, Eiji
    Ito, Toshifumi
    Fukui, Hiroyuki
    Inui, Yoshiaki
    Hijioka, Taizo
    Inada, Masami
    Kaytayama, Kazuhiro
    Tamura, Shinji
    Yoshihara, Harumasa
    Inoue, Atsuo
    Imai, Yasuharu
    Kato, Michio
    Miyagi, Takuya
    Yoshida, Yuichi
    Tatsumi, Tomohide
    Kiso, Shinichi
    Kanto, Tatsuya
    Kasahara, Akinori
    Takehara, Tetsuo
    Hayashi, Norio
    JOURNAL OF HEPATOLOGY, 2011, 54 (04) : 604 - 611
  • [10] Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C non responders to interferon monotherapy or standard combination therapy
    Chousterman, N
    Auray-Cartier, V
    Hagege, H
    Arpurt, JP
    Cassan, P
    Denis, J
    Gargot, D
    Nalet, B
    Nouel, O
    Pariente, A
    Wartelle-Bladou, C
    HEPATOLOGY, 2002, 36 (04) : 362A - 362A
12345